These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34627435)

  • 1. [Clinical Characteristics of Myelodysplastic Syndrome with Patients Chromosome 21 Karyotype Abnormality].
    Qian J; Xia J; Xie X; Wang J; Mao JJ; Zhou X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1528-1532. PubMed ID: 34627435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
    Wang W; Chen Z; Yu M; Wang H; Lou J; Xu H; Hu C; Mu Q; Tong H; Wei J; Zhou X; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):818-23. PubMed ID: 26477758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on karyotypic abnormalities and its prognostic significance in Chinese patients with primary myelodysplastic syndromes].
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):217-22. PubMed ID: 19731819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic features in primary myelodysplastic syndrome Egyptian patients.
    Elnahass Y; Youssif L
    J Adv Res; 2018 Mar; 10():77-83. PubMed ID: 30046476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relevance between quantitative and type of chromosomal abnormality and leukemia transformation in myelodysplastic syndrome].
    Li Y; Li WW; Wang XM; An L; Liu H; Wang ZS; Xiao ZJ; Qin TJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):221-4. PubMed ID: 23683420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
    Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Significance of Monosomal Karyotype in MDS].
    Guo SS; Gao PP; Mu QT; Ouyang GF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):860-866. PubMed ID: 31204945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan.
    Tasaka T; Tohyama K; Kishimoto M; Ohyashiki K; Mitani K; Hotta T; Kanamaru A; Okamoto S; Karasawa M; Kimura A; Tomonaga M; Uchiyama T; Ozawa K;
    Leukemia; 2008 Oct; 22(10):1874-81. PubMed ID: 18668133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities in primary myelodysplastic syndrome.
    Rashid A; Khurshid M; Shaikh U; Adil S
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
    Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
    Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
    Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of bone marrow cell morphology in a cohort of patients with isolated idic(20q-) karyotypic abnormalities.
    Liu D; Pan J; Wu C; Liang J; Wang J; Chen S; Chen Z
    Ann Hematol; 2019 Mar; 98(3):605-614. PubMed ID: 30483862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients.
    Liu L; Wang J; Jiang Y; Xie H; Tang X; Li Q; Wang H; Zou P; Miao Z; Lv Y; Wang H; Cao Z; Zhao Z
    Leuk Lymphoma; 2018 Dec; 59(12):2929-2940. PubMed ID: 29846125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
    Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
    Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
    Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
    Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.